Buyout buzz: Royalty might mount joint effort to acquire Elan

Ryan McBride

In the latest twist in Pharma's plot to buy , the business press has caught wind that may decide to revive its pursuit of Elan with the help and financial support of a partner. This scenario involves multiple factors, including Elan's willingness to take offers from bidders, and none of the players is commenting on the record about the situation.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS